Actuate Therapeutics ACTU
NASDAQ ACTU
$0.30 -0.02 (-5.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Actuate Therapeutics (ACTU) EBIT (2023 - 2026)

Updated

Actuate Therapeutics' EBIT came in at -$4.91 million for Q2 2026, compared with -$5.97 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) EBIT (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Actuate Therapeutics reported EBIT of -$21.04 million; for FY2025, it was -$22.5 million.

  • Going back by year, EBIT was -$25.16 million in FY2024 and -$24.97 million in FY2023.
  • The five-year range for quarterly EBIT is -$7.77 million (Q1 2024) to -$4.69 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 6.18 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 6.27 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.59 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 3.16 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.46 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.47 Bn
10 Actuate Therapeutics 7.56 Mn -35.08 Mn - -4.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.91 Mn
Dec 31, 2025 -4.69 Mn
Sep 30, 2025 -5.47 Mn
Jun 30, 2025 -5.97 Mn
Mar 31, 2025 -6.37 Mn
Dec 31, 2024 -6.56 Mn
Sep 30, 2024 -5.39 Mn
Jun 30, 2024 -5.44 Mn
Mar 31, 2024 -7.77 Mn
Dec 31, 2023 -7.62 Mn
Sep 30, 2023 -6.48 Mn
Jun 30, 2023 -5.58 Mn
API Access

Actuate Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ACTU&period=max&api_key=YOUR_API_KEY